All Stories

  1. Awareness of the link between human papillomavirus and oral cancer in UK university students

    Article • Preventive Medicine, September 2021, Elsevier

    Professor Peter Sasieni

  2. Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data

    Article • EClinicalMedicine, July 2021, Elsevier

    Professor Peter Sasieni

  3. The impact of excluding or including Death Certificate Initiated (DCI) cases on estimated cancer survival: A simulation study

    Article • Cancer Epidemiology, April 2021, Elsevier

    Professor Peter Sasieni

  4. Multizonal anogenital neoplasia in women: a cohort analysis

    Article • BMC Cancer, March 2021, Springer Science + Business Media

    Professor Peter Sasieni

  5. Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses

    Article • British Journal of Cancer, February 2021, Springer Science + Business Media

    Professor Peter Sasieni

  6. Reply to ‘Intraoperative radiotherapy for breast cancer: powerful evidence to change practice’

    Article • Nature Reviews Clinical Oncology, January 2021, Springer Science + Business Media

    Professor Peter Sasieni

  7. Overdiagnosis in lung cancer screening

    Article • The Lancet Respiratory Medicine, January 2021, Elsevier

    Professor Peter Sasieni

  8. Introducing human papillomavirus (HPV) primary testing in the age of HPV vaccination: projected impact on colposcopy services in Wales

    Article • BJOG An International Journal of Obstetrics & Gynaecology, December 2020, Wiley

    Professor Peter Sasieni

  9. Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study

    Article • British Journal of Cancer, December 2020, Springer Science + Business Media

    Professor Peter Sasieni

  10. The impact of COVID-19 disruption to cervical cancer screening in England on excess diagnoses

    Article • November 2020, Cold Spring Harbor Laboratory Press

    Professor Peter Sasieni

  11. A case-control study to evaluate the impact of the breast screening programme on mortality in England

    Article • British Journal of Cancer, November 2020, Springer Science + Business Media

    Professor Peter Sasieni

  12. A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States

    Article • Gynecologic Oncology, November 2020, Elsevier

    Professor Peter Sasieni

  13. Comparison of immediate colposcopy, repeat conventional cytology and high‐risk human papillomavirus testing for the clinical management of atypical squamous cells of undetermined significance cytology in routine health services of Medellin, Colombia: T...

    Article • International Journal of Cancer, October 2020, Wiley

    Professor Peter Sasieni

  14. Intraoperative radiotherapy for early breast cancer — insufficient evidence to change practice

    Article • Nature Reviews Clinical Oncology, October 2020, Springer Science + Business Media

    Professor Peter Sasieni

  15. Cancer Screening, Surrogates of Survival, and the Soma

    Article • Cancer Cell, October 2020, Elsevier

    Professor Peter Sasieni

  16. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT

    Article • Health Technology Assessment, October 2020, National Institute for Health Research

    Professor Peter Sasieni

  17. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial

    Article • The Lancet Oncology, September 2020, Elsevier

    Professor Peter Sasieni

  18. Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study

    Article • Journal of Medical Screening, August 2020, SAGE Publications

    Professor Peter Sasieni

  19. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

    Article • The Lancet, August 2020, Elsevier

    Mr Ben Bowers, Professor Peter Sasieni

  20. Can different definitions of date of cancer incidence explain observed international variation in cancer survival? An ICBP SURVMARK-2 study

    Article • Cancer Epidemiology, August 2020, Elsevier

    Professor Peter Sasieni

  21. Lectins in Cervical Screening

    Article • Cancers, July 2020, MDPI AG

    Professor Peter Sasieni

  22. Evidence of HPV vaccination efficacy comes from more than clinical trials

    Article • Vaccine, July 2020, Elsevier

    Professor Peter Sasieni

  23. WELCOME-GP: A randomised controlled trial of the effectiveness of a targeted postal cancer awareness intervention for increasing attendance at general practice

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Professor Peter Sasieni

  24. Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)

    Article • British Journal of Cancer, June 2020, Springer Science + Business Media

    Professor Peter Sasieni

  25. Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic

    Article • Royal Society Open Science, June 2020, Royal Society Publishing

    Professor Peter Sasieni

  26. Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial

    Article • The Lancet, March 2020, Elsevier

    Professor Peter Sasieni

  27. Errors in determination of net survival: cause-specific and relative survival settings

    Article • British Journal of Cancer, February 2020, Springer Science + Business Media

    Professor Peter Sasieni

  28. Population-level impact of human papillomavirus vaccination

    Article • The Lancet, February 2020, Elsevier

    Professor Peter Sasieni

  29. High-dose oral vitamin D supplementation and mortality in people aged 65–84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation

    Article • Health Technology Assessment, February 2020, National Institute for Health Research

    Professor Peter Sasieni

  30. Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approach

    Article • The Lancet Digital Health, January 2020, Elsevier

    Professor Peter Sasieni

  31. Impact of screening on cervical cancer incidence: A population‐based case–control study in the United States

    Article • International Journal of Cancer, December 2019, Wiley

    Professor Peter Sasieni

  32. Cost‐effectiveness of e‐cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial

    Article • Addiction, December 2019, Wiley

    Professor Peter Sasieni

  33. Flexible use of flexible sigmoidoscopy

    Article • Journal of Medical Screening, November 2019, SAGE Publications

    Professor Peter Sasieni

  34. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study

    Article • The Lancet Oncology, November 2019, Elsevier

    Professor Peter Sasieni

  35. Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts

    Article • The Lancet Oncology, November 2019, Elsevier

    Professor Peter Sasieni

  36. Equality and equity in medical screening: what is fair?

    Article • The Lancet Gastroenterology & Hepatology, August 2019, Elsevier

    Professor Peter Sasieni

  37. E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT

    Article • Health Technology Assessment, August 2019, National Institute for Health Research

    Professor Peter Sasieni

  38. Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol

    Article • The Lancet Respiratory Medicine, August 2019, Elsevier

    Professor Peter Sasieni

  39. A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method

    Article • BMC Cancer, June 2019, Springer Science + Business Media

    Professor Peter Sasieni

  40. Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting

    Article • International Journal of Cancer, April 2019, Wiley

    Professor Peter Sasieni

  41. Lung cancer mortality in Australia in the twenty-first century: How many lives can be saved with effective tobacco control?

    Article • Lung Cancer, April 2019, Elsevier

    Dr Julia Steinberg, Professor Peter Sasieni

  42. The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome

    Article • Genetics in Medicine, March 2019, Springer Science + Business Media

    Dr Kevin J Monahan, Professor Peter Sasieni

  43. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 2019, New England Journal of Medicine (NEJM/MMS)

    Professor Peter Sasieni

  44. Cancer elimination thresholds: one size does not fit all

    Article • The Lancet Public Health, February 2019, Elsevier

    Professor Peter Sasieni

  45. Development and validation of a haematuria cancer risk score to identify patients at risk of harbouring cancer

    Article • Journal of Internal Medicine, January 2019, Wiley

    Professor Peter Sasieni

  46. Impact of screening on cervical cancer incidence in England: a time trend analysis

    Article • BMJ Open, January 2019, BMJ

    Professor Peter Sasieni

  47. Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany

    Article • Journal of Clinical Microbiology, October 2018, ASM Journals

    Professor Peter Sasieni

  48. Is a delay in the introduction of human papillomavirus-based cervical screening affordable?

    Article • Journal of Medical Screening, October 2018, SAGE Publications

    Mrs Alejandra Castanon, Professor Peter Sasieni

  49. Global perspectives surrounding cancer prevention and screening

    Article • August 2018, Wiley

    Professor Peter Sasieni

  50. Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux

    Article • BMC Cancer, August 2018, Springer Science + Business Media

    Professor Peter Sasieni

  51. When should the errors in the UK's breast screening programme have been spotted?

    Article • The Lancet, June 2018, Elsevier

    Professor Peter Sasieni

  52. Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records

    Article • Preventive Medicine, June 2018, Elsevier

    Professor Peter Sasieni

  53. Exercise training as a novel primary treatment for localised prostate cancer: a multi-site randomised controlled phase II study

    Article • Scientific Reports, May 2018, Springer Science + Business Media

    Professor Peter Sasieni

  54. The acceptability of high resolution anoscopy examination in patients attending a tertiary referral centre

    Article • BMC Cancer, May 2018, Springer Science + Business Media

    Professor Peter Sasieni

  55. Evaluation of Dried Blood Spots and Oral Fluids as Alternatives to Serum for Human Papillomavirus Antibody Surveillance

    Article • mSphere, May 2018, ASM Journals

    Professor Peter Sasieni

  56. The IARC Perspective on Colorectal Cancer Screening

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2018, New England Journal of Medicine (NEJM/MMS)

    Professor Peter Sasieni

  57. Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037

    Article • British Journal of Cancer, March 2018, Springer Science + Business Media

    Professor Peter Sasieni

  58. Acceptability of non-speculum clinician sampling for cervical screening in older women: A qualitative study

    Article • Journal of Medical Screening, February 2018, SAGE Publications

    Professor Peter Sasieni

  59. Is the recent increase in cervical cancer in women aged 20–24 years in England a cause for concern?

    Article • Preventive Medicine, February 2018, Elsevier

    Professor Peter Sasieni

  60. Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study

    Article • The Lancet Public Health, January 2018, Elsevier

    Professor Peter Sasieni

  61. Cancer incidence in English children, adolescents and young people: past trends and projections to 2030

    Article • British Journal of Cancer, November 2017, Springer Science + Business Media

    Professor Peter Sasieni

  62. What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study

    Article • International Journal of Cancer, October 2017, Wiley

    Professor Peter Sasieni

  63. Systematic Review and Meta-Analysis of Individual Patient Data to Assess the Sensitivity of Cervical Cytology for Diagnosis of Cervical Cancer in Low- and Middle-Income Countries

    Article • Journal of Global Oncology, October 2017, American Society of Clinical Oncology (ASCO)

    Roshni Bhudia, Professor Peter Sasieni

  64. Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline

    Article • Journal of Global Oncology, October 2017, American Society of Clinical Oncology (ASCO)

    Professor Peter Sasieni

  65. Colorectal adenomas, surveillance, and cancer – Authors' reply

    Article • The Lancet Oncology, August 2017, Elsevier

    Professor Peter Sasieni

  66. Article • Oncotarget, August 2017, Impact Journals, LLC

    Professor Peter Sasieni

  67. Article • Statistics in Medicine, July 2017, Wiley

    Professor Peter Sasieni

  68. Should a Reduction in All-Cause Mortality Be the Goal When Assessing Preventive Medical Therapies?

    Article • Circulation, May 2017, Wolters Kluwer Health

    Professor Peter Sasieni

  69. Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions

    Article • Oncotarget, May 2017, Impact Journals, LLC

    Professor Peter Sasieni

  70. Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline

    Article • Obstetrical & Gynecological Survey, May 2017, Wolters Kluwer Health

    Professor Peter Sasieni

  71. Medicine is the ultimate personalised technology

    Article • BMJ, April 2017, BMJ

    Professor Peter Sasieni

  72. Urgent improvements needed to diagnose and manage Lynch syndrome

    Article • BMJ, March 2017, BMJ

    Dr Kevin J Monahan, Professor Peter Sasieni

  73. Estimating the effect of treatment when patients in the control arm later take the new treatment

    Article • Statistics in Medicine, March 2017, Wiley

    Professor Peter Sasieni

  74. Acceptability of the Cytosponge procedure for detecting Barrett's oesophagus: a qualitative study

    Article • BMJ Open, March 2017, BMJ

    Professor Peter Sasieni

  75. Both a stage shift and changes in stage-specific survival have contributed to reductions in breast cancer mortality

    Article • Evidence-Based Medicine, February 2017, BMJ

    Professor Peter Sasieni

  76. Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study

    Article • The Lancet Gastroenterology & Hepatology, January 2017, Elsevier

    Professor Peter Sasieni, Kareem Shariff

  77. Factors related to inter-observer reproducibility of conventional Pap smear cytology: a multilevel analysis of smear and laboratory characteristics

    Article • Cytopathology, December 2016, Wiley

    Professor Peter Sasieni

  78. Cancer risks in Nairobi (2000-2014) by ethnic group

    Article • International Journal of Cancer, November 2016, Wiley

    Ms Anne Rugutt Korir, Professor Peter Sasieni

  79. Cytology in the diagnosis of cervical cancer in symptomatic young women: a retrospective review

    Article • British Journal of General Practice, October 2016, Royal College of General Practitioners

    Professor Peter Sasieni

  80. Range of pathologies diagnosed using a minimally invasive capsule sponge to evaluate patients with reflux symptoms

    Article • Histopathology, October 2016, Wiley

    Professor Peter Sasieni

  81. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study

    Article • British Journal of Cancer, September 2016, Springer Science + Business Media

    Professor Peter Sasieni

  82. On standardized relative survival

    Article • Biometrics, August 2016, Wiley

    Professor Peter Sasieni

  83. By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?

    Article • Journal of Medical Screening, June 2016, SAGE Publications

    Mrs Alejandra Castanon, Professor Peter Sasieni

  84. Offering self-sampling to cervical screening non-attenders in primary care

    Article • Journal of Medical Screening, June 2016, SAGE Publications

    Professor Peter Sasieni

  85. Ovarian cancer screening: UKCTOCS trial

    Article • The Lancet, June 2016, Elsevier

    Professor Peter Sasieni

  86. Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?

    Article • International Journal of Cancer, May 2016, Wiley

    Mrs Alejandra Castanon, Professor Peter Sasieni

  87. Impact of Screening on Breast Cancer Mortality—Response

    Article • Cancer Epidemiology Biomarkers & Prevention, May 2016, American Association for Cancer Research (AACR)

    Professor Peter Sasieni

  88. Performance characteristics of visualising the cervix in symptomatic young females: a review of primary care records in females with and without cervical cancer

    Article • British Journal of General Practice, February 2016, Royal College of General Practitioners

    Professor Peter Sasieni

  89. The age of cervical screening should be reduced

    Article • BJOG An International Journal of Obstetrics & Gynaecology, January 2016, Wiley

    Professor Peter Sasieni

  90. Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART

    Article • Journal of Antimicrobial Chemotherapy, December 2015, Oxford University Press (OUP)

    Professor Peter Sasieni, Dr. Vicente Soriano

  91. Risk of preterm birth following surgical treatment for cervical disease: executive summary of a recent symposium

    Article • BJOG An International Journal of Obstetrics & Gynaecology, December 2015, Wiley

    Professor Peter Sasieni

  92. Explaining the Better Prognosis of Screening-Exposed Breast Cancers: Influence of Tumor Characteristics and Treatment

    Article • Cancer Epidemiology Biomarkers & Prevention, December 2015, American Association for Cancer Research (AACR)

    Professor Peter Sasieni

  93. Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years On

    Article • Cancer Epidemiology Biomarkers & Prevention, December 2015, American Association for Cancer Research (AACR)

    Professor Peter Sasieni

  94. Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy

    Article • HIV Medicine, November 2015, Wiley

    Dr. Vicente Soriano, Professor Peter Sasieni

  95. Analysis of trends is insufficient to posit the existence of two aetiological types of cervical cancer

    Article • BJOG An International Journal of Obstetrics & Gynaecology, November 2015, Wiley

    Professor Peter Sasieni

  96. Response to Hersch et al.

    Article • Journal of Medical Screening, November 2015, SAGE Publications

    Professor Peter Sasieni

  97. Black-white differences in cancer risk in Harare, Zimbabwe, during 1991-2010

    Article • International Journal of Cancer, October 2015, Wiley

    Professor Peter Sasieni

  98. How many preterm births in England are due to excision of the cervical transformation zone? Nested case control study

    Article • BMC Pregnancy and Childbirth, September 2015, Springer Science + Business Media

    Professor Peter Sasieni

  99. Cervical cytology and the diagnosis of cervical cancer in older women

    Article • Journal of Medical Screening, September 2015, SAGE Publications

    Professor Peter Sasieni

  100. Interventions in randomised controlled trials in surgery: issues to consider during trial design

    Article • Trials, September 2015, Springer Science + Business Media

    Mr Angelos Kolias, Professor Peter Sasieni, Catrin Tudur Smith

  101. MSLT ‐I: it's all about the lymph nodes…: reply from the authors

    Article • British Journal of Dermatology, July 2015, Wiley

    Professor Peter Sasieni

  102. Evaluating cytology for the detection of invasive cervical cancer

    Article • Cytopathology, June 2015, Wiley

    Mrs Alejandra Castanon, Professor Peter Sasieni

  103. Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records

    Article • BJOG An International Journal of Obstetrics & Gynaecology, May 2015, Wiley

    Professor Peter Sasieni

  104. Are rigid management protocols stifling innovation in cancer treatment?

    Article • BJOG An International Journal of Obstetrics & Gynaecology, May 2015, Wiley

    Professor Peter Sasieni

  105. clinical performance of the RNA based Aptima HPV test

    Article • Journal of Clinical Microbiology, May 2015, ASM Journals

    Professor Thomas Iftner, Professor Peter Sasieni

  106. Informed Decision-Making and Breast Cancer Screening

    Article • Journal of Medical Screening, May 2015, SAGE Publications

    Professor Peter Sasieni

  107. Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis

    Article • Annals of Oncology, May 2015, Elsevier

    Professor Peter Sasieni

  108. Reply to the letter to the editor ‘Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis’ by Louie et al.

    Article • Annals of Oncology, May 2015, Elsevier

    Professor Peter Sasieni

  109. Is the increased risk of preterm birth following excision for cervical intraepithelial neoplasia restricted to the first birth post treatment?

    Article • BJOG An International Journal of Obstetrics & Gynaecology, April 2015, Wiley

    Mrs Alejandra Castanon, Professor Peter Sasieni

  110. Trends in head and neck cancers in England from 1995 to 2011 and projections up to 2025

    Article • Oral Oncology, April 2015, Elsevier

    Professor Peter Sasieni

  111. Consultation rates in cervical screening non-attenders: opportunities to increase screening uptake in GP primary care

    Article • Journal of Medical Screening, March 2015, SAGE Publications

    Professor Peter Sasieni

  112. Sentinel node biopsy in cutaneous melanoma: time for consensus to better inform patient choice

    Article • British Journal of Dermatology, March 2015, Wiley

    Professor Peter Sasieni

  113. Development and Validation of a Melanoma Risk Score Based on Pooled Data from 16 Case–Control Studies

    Article • Cancer Epidemiology Biomarkers & Prevention, February 2015, American Association for Cancer Research (AACR)

    Professor Peter Sasieni

  114. Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960

    Article • British Journal of Cancer, February 2015, Springer Science + Business Media

    Professor Peter Sasieni

  115. Visual Inspection after Acetic Acid (VIA) Is Highly Heterogeneous in Primary Cervical Screening in Amazonian Peru

    Article • PLoS ONE, January 2015, PLOS

    Professor Peter Sasieni

  116. Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study

    Article • PLoS Medicine, January 2015, PLOS

    Professor Peter Sasieni, Kareem Shariff

  117. An ongoing case–control study to evaluate the NHS Bowel Cancer Screening Programme

    Article • BMC Cancer, December 2014, Springer Science + Business Media

    Professor Peter Sasieni

  118. Estimating the workload associated with symptoms-based ovarian cancer screening in primary care: an audit of electronic medical records

    Article • BMC Family Practice, December 2014, Springer Science + Business Media

    Professor Peter Sasieni

  119. Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study

    Article • BMJ, November 2014, BMJ

    Professor Peter Sasieni

  120. C ox Regression Model

    Article • September 2014, Wiley

    Professor Peter Sasieni

  121. Semiparametric Regression

    Article • September 2014, Wiley

    Professor Peter Sasieni

  122. Delays in diagnosis of young females with symptomatic cervical cancer in England: an interview-based study

    Article • British Journal of General Practice, September 2014, Royal College of General Practitioners

    Professor Peter Sasieni

  123. Response to comment on ‘Characteristics and screening history of women diagnosed with cervical cancer aged 20–29’

    Article • British Journal of Cancer, August 2014, Springer Science + Business Media

    Professor Peter Sasieni

  124. A prospective double-blind cross-sectional study of the accuracy of the use of dry vaginal tampons for self-sampling of human papillomaviruses

    Article • BJOG An International Journal of Obstetrics & Gynaecology, August 2014, Wiley

    Professor Peter Sasieni

  125. The difference in sensitivity between HPV testing and cytology for detecting current and future CIN2+ increases over time

    Article • Evidence-Based Medicine, May 2014, BMJ

    Professor Peter Sasieni

  126. Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years

    Article • British Journal of Cancer, February 2014, Springer Science + Business Media

    Professor Peter Sasieni

  127. Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study

    Article • PLoS Medicine, January 2014, PLOS

    Professor Peter Sasieni

  128. Survival Analysis

    Article • January 2014, Springer Science + Business Media

    Professor Peter Sasieni

  129. An ongoing case-control study to evaluate the NHS breast screening programme

    Article • BMC Cancer, December 2013, Springer Science + Business Media

    Professor Peter Sasieni

  130. New Strategies for Human Papillomavirus-Based Cervical Screening

    Article • Women s Health, September 2013, SAGE Publications

    Professor Peter Sasieni

  131. A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer

    Article • International Journal of Cancer, August 2013, Wiley

    Professor Peter Sasieni

  132. Characteristics and screening history of women diagnosed with cervical cancer aged 20–29 years

    Article • British Journal of Cancer, July 2013, Springer Science + Business Media

    Professor Peter Sasieni

  133. How much could primary human papillomavirus testing reduce cervical cancer incidence and morbidity?

    Article • Journal of Medical Screening, June 2013, SAGE Publications

    Professor Peter Sasieni

  134. Pregnancy Outcomes After Treatment for Cervical Intraepithelial Neoplasia in a Single NHS Hospital

    Article • International Journal of Gynecological Cancer, May 2013, BMJ

    Professor Peter Sasieni

  135. Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes

    Article • The Journal of Pathology, March 2013, Wiley

    Francesco Di Maggio, Professor Peter Sasieni

  136. HPV16 L1 and L2 DNA methylation predicts high‐grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology

    Article • International Journal of Cancer, March 2013, Wiley

    Professor Peter Sasieni

  137. Reply to ‘Comment on Cancer incidence in the United Kingdom: projections to the year 2030’

    Article • British Journal of Cancer, February 2013, Springer Science + Business Media

    Professor Peter Sasieni

  138. Characteristics of HPV infection over time in European women who are HIV-1 positive

    Article • BJOG An International Journal of Obstetrics & Gynaecology, November 2012, Wiley

    Professor Peter Sasieni

  139. A Surveillance Model for Skin Cancer in Organ Transplant Recipients: A 22-Year Prospective Study in an Ethnically Diverse Population

    Article • American Journal of Transplantation, October 2012, Wiley

    Professor Peter Sasieni

  140. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus

    Article • Nature Genetics, September 2012, Springer Science + Business Media

    Dr Iain A Murray, Professor Janusz Antoni Jankowski, Professor Peter Sasieni

  141. Dramatic increase in cervical cancer registrations in young women in 2009 in England unlikely to be due to the new policy not to screen women aged 20–24

    Article • Journal of Medical Screening, September 2012, SAGE Publications

    Professor Peter Sasieni

  142. Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study

    Article • BMJ, August 2012, BMJ

    Professor Peter Sasieni

  143. Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing

    Article • British Journal of Cancer, June 2012, Springer Science + Business Media

    Professor Peter Sasieni

  144. The impact of Jade Goody's diagnosis and death on the NHS Cervical Screening Programme

    Article • Journal of Medical Screening, May 2012, SAGE Publications

    Professor Peter Sasieni

  145. Cervical cancer incidence in young women: a historical and geographic controlled UK regional population study

    Article • British Journal of Cancer, April 2012, Springer Science + Business Media

    Professor Peter Sasieni

  146. Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model

    Article • BMJ, March 2012, BMJ

    Professor Peter Sasieni

  147. Screening mammography and socioeconomic inequalities in breast cancer survival

    Article • Annals of Oncology, February 2012, Elsevier

    Professor Peter Sasieni

  148. Predictive Value of Symptoms for Ovarian Cancer: Comparison of Symptoms Reported by Questionnaire, Interview, and General Practitioner Notes

    Article • JNCI Journal of the National Cancer Institute, January 2012, Oxford University Press (OUP)

    Professor Peter Sasieni

  149. Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers

    Article • Cytopathology, January 2012, Wiley

    Professor Peter Sasieni

  150. 13. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010

    Article • British Journal of Cancer, December 2011, Springer Science + Business Media

    Professor Peter Sasieni

  151. Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial

    Article • British Journal of Cancer, November 2011, Springer Science + Business Media

    Professor Peter Sasieni

  152. Risk Factors for High-Risk Human Papillomavirus Infection and Cofactors for High-Grade Cervical Disease in Peru

    Article • International Journal of Gynecological Cancer, November 2011, BMJ

    Professor Peter Sasieni

  153. Cancer incidence in the United Kingdom: projections to the year 2030

    Article • British Journal of Cancer, October 2011, Springer Science + Business Media

    Professor Peter Sasieni

  154. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines

    Article • Best Practice & Research Clinical Obstetrics & Gynaecology, October 2011, Elsevier

    Professor Peter Sasieni

  155. Evaluation of the nationwide cervical screening programme in Thailand: a case-control study

    Article • Journal of Medical Screening, September 2011, SAGE Publications

    Professor Peter Sasieni

  156. Single negative colposcopy: is it enough to rule out high-grade disease?

    Article • Journal of Medical Screening, September 2011, SAGE Publications

    Professor Peter Sasieni

  157. What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries

    Article • British Journal of Cancer, July 2011, Springer Science + Business Media

    Professor Peter Sasieni

  158. Safe thresholds for hybrid capture 2 test in primary cervical screening

    Article • BMJ, May 2011, BMJ

    Professor Peter Sasieni

  159. Eurogin 2010 roadmap on cervical cancer prevention

    Article • International Journal of Cancer, March 2011, Wiley

    Professor Peter Sasieni

  160. In defence of lifetime risk

    Article • BMJ, March 2011, BMJ

    Professor Peter Sasieni

  161. Epidemiology of gynaecological cancer

    Article • January 2011, Elsevier

    Mrs Alejandra Castanon, Professor Peter Sasieni

  162. Assessing Peanut Consumption in a Population of Mothers and Their Children in the UK

    Article • World Allergy Organization Journal, January 2011, Elsevier

    Professor Peter Sasieni

  163. ACOG Guidelines on Cervical Screening: A Step in the Right Direction

    Article • Journal of Medical Screening, June 2010, SAGE Publications

    Professor Peter Sasieni

  164. Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy

    Article • British Journal of Cancer, May 2010, Springer Science + Business Media

    Professor Peter Sasieni

  165. Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study

    Article • British Journal of Cancer, March 2010, Springer Science + Business Media

    Professor Peter Sasieni

  166. Has Cytology Become Obsolete as a Primary Test in Screening for Cervical Cancer?

    Article • Journal of Medical Screening, March 2010, SAGE Publications

    Professor Peter Sasieni

  167. Effect of the correction for noncompliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section Rotterdam)

    Article • International Journal of Cancer, March 2010, Wiley

    Professor Peter Sasieni

  168. Modelling the likely effect of the increase of the upper age limit from 70 to 73 for breast screening in the UK National Programme

    Article • Statistical Methods in Medical Research, February 2010, SAGE Publications

    Professor Peter Sasieni

  169. Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK

    Article • British Journal of Cancer, January 2010, Springer Science + Business Media

    Professor Peter Sasieni

  170. What is the Right Age for Cervical Cancer Screening?

    Article • Women s Health, January 2010, SAGE Publications

    Professor Peter Sasieni

  171. Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

    Article • European Urology, October 2009, Elsevier

    Professor Peter Sasieni

  172. Further analysis of the ARTISTIC trial

    Article • The Lancet Oncology, September 2009, Elsevier

    Professor Peter Sasieni

  173. Screening and adenocarcinoma of the cervix

    Article • International Journal of Cancer, August 2009, Wiley

    Mrs Alejandra Castanon, Professor Peter Sasieni

  174. Reply

    Article • Journal of Allergy and Clinical Immunology, August 2009, Elsevier

    Professor Peter Sasieni

  175. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

    Article • BMJ, July 2009, BMJ

    Professor Peter Sasieni

  176. Prospective observational study: cervical cancer smears

    Article • BMJ, July 2009, BMJ

    Professor Peter Sasieni

  177. The potential for prevention of colorectal cancer in the UK

    Article • European Journal of Cancer Prevention, June 2009, Wolters Kluwer Health

    Professor Peter Sasieni

  178. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls

    Article • International Journal of Epidemiology, April 2009, Oxford University Press (OUP)

    Professor Peter Sasieni

  179. Household peanut consumption as a risk factor for the development of peanut allergy

    Article • Journal of Allergy and Clinical Immunology, February 2009, Elsevier

    Professor Peter Sasieni

  180. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes

    Article • International Journal of Cancer, January 2009, Wiley

    Professor Peter Sasieni

  181. How many cervical cancers are prevented by treatment of screen-detected disease in young women?

    Article • International Journal of Cancer, January 2009, Wiley

    Professor Peter Sasieni

  182. Response to: Why young women should be screened for cervical cancer: The distinction between CIN2 and CIN3

    Article • International Journal of Cancer, January 2009, Wiley

    Professor Peter Sasieni

  183. Predicting the impact of the screening programme for colorectal cancer in the UK

    Article • Journal of Medical Screening, December 2008, SAGE Publications

    Professor Peter Sasieni

  184. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy

    Article • Journal of Allergy and Clinical Immunology, November 2008, Elsevier

    Professor Peter Sasieni

  185. Cancer mortality in the United Kingdom: projections to the year 2025

    Article • British Journal of Cancer, October 2008, Springer Science + Business Media

    Professor Peter Sasieni

  186. A deterministic model for estimating the reduction in colorectal cancer incidence due to endoscopic surveillance

    Article • Statistical Methods in Medical Research, April 2008, SAGE Publications

    Professor Peter Sasieni

  187. Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study

    Article • International Journal of Cancer, January 2008, Wiley

    Professor Peter Sasieni

  188. Cervical cancer prevention and hormonal contraception

    Article • The Lancet, November 2007, Elsevier

    Professor Peter Sasieni

  189. Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC)

    Article • Familial Cancer, October 2007, Springer Science + Business Media

    Professor Peter Sasieni

  190. Replication Timing Profile Reflects the Distinct Functional and Genomic Features of the MHC Class II Region

    Article • Cell Cycle, October 2007, Taylor & Francis

    Professor Peter Sasieni

  191. Estimating the effect of treatment in a proportional hazards model in the presence of non-compliance and contamination

    Article • Journal of the Royal Statistical Society Series B Statistical Methodology, September 2007, Wiley

    Professor Peter Sasieni

  192. Phenocopies in families seen by cancer geneticists

    Article • Journal of Medical Genetics, February 2007, BMJ

    Professor Peter Sasieni

  193. Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru

    Article • International Journal of Cancer, January 2007, Wiley

    Professor Peter Sasieni

  194. Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: An international cohort study of cervical pathology in HIV-1 positive women

    Article • International Journal of Cancer, January 2007, Wiley

    Professor Peter Sasieni

  195. Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses

    Article • Vaccine, August 2006, Elsevier

    Professor Peter Sasieni

  196. Cervical screening in 20–24-year olds

    Article • Journal of Medical Screening, June 2006, SAGE Publications

    Professor Peter Sasieni

  197. Prospective Results of Surveillance Colonoscopy in Dominant Familial Colorectal Cancer With and Without Lynch Syndrome

    Article • Gastroenterology, June 2006, Elsevier

    Professor Peter Sasieni

  198. A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH

    Article • Oncogene, May 2006, Springer Science + Business Media

    Professor Peter Sasieni

  199. Liquid-based versus conventional cervical cytology

    Article • The Lancet, May 2006, Elsevier

    Professor Peter Sasieni

  200. Call and recall cervical screening programme: Screening interval and age limits

    Article • Current Diagnostic Pathology, April 2006, Elsevier

    Professor Peter Sasieni

  201. Chemoprevention of cervical cancer

    Article • Best Practice & Research Clinical Obstetrics & Gynaecology, April 2006, Elsevier

    Professor Peter Sasieni

  202. Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen?

    Article • British Journal of Cancer, January 2006, Springer Science + Business Media

    Professor Peter Sasieni

  203. Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission

    Article • Proceedings of the National Academy of Sciences, January 2006, Proceedings of the National Academy of Sciences

    Professor Janusz Antoni Jankowski, Professor Peter Sasieni

  204. Overview of the European and North American studies on HPV testing in primary cervical cancer screening

    Article • International Journal of Cancer, January 2006, Wiley

    Professor Thomas Iftner, Professor Peter Sasieni

  205. Methodological issues in international comparison of interval breast cancers

    Article • International Journal of Cancer, January 2006, Wiley

    Professor Peter Sasieni

  206. Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia

    Article • International Journal of Cancer, November 2005, Wiley

    Professor Peter Sasieni

  207. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study

    Article • BMJ, October 2005, BMJ

    Professor Peter Sasieni

  208. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe

    Article • European Journal of Cancer, September 2005, Elsevier

    Professor Peter Sasieni

  209. Cox Regression Model

    Article • July 2005, Wiley

    Professor Peter Sasieni

  210. Semiparametric Regression

    Article • July 2005, Wiley

    Professor Peter Sasieni

  211. Refining the Amsterdam Criteria and Bethesda Guidelines: Testing Algorithms for the Prediction of Mismatch Repair Mutation Status in the Familial Cancer Clinic

    Article • Journal of Clinical Oncology, December 2004, American Society of Clinical Oncology (ASCO)

    Professor Peter Sasieni

  212. Cervical screening in adolescents—at least do no harm

    Article • The Lancet, November 2004, Elsevier

    Professor Peter Sasieni

  213. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin

    Article • British Journal of Dermatology, May 2004, Wiley

    Professor Peter Sasieni

  214. Reply: The value of case—control audits of screening

    Article • British Journal of Cancer, March 2004, Springer Science + Business Media

    Professor Peter Sasieni

  215. The value of cervical screening to young women

    Article • British Journal of Cancer, March 2004, Springer Science + Business Media

    Professor Peter Sasieni

  216. Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions

    Article • Journal of Cell Biology, February 2004, Rockefeller University Press

    Professor Peter Sasieni

  217. Exposure to the sun and sunbeds and the risk of cutaneous melanoma in the UK: a case–control study

    Article • European Journal of Cancer, February 2004, Elsevier

    Professor Peter Sasieni

  218. Management of women who test positive for high-risk types of human papillomavirus: the HART study

    Article • The Lancet, December 2003, Elsevier

    Professor Peter Sasieni

  219. Martingale difference residuals as a diagnostic tool for the Cox model

    Article • Biometrika, December 2003, Oxford University Press (OUP)

    Professor Peter Sasieni

  220. Evaluation of the UK breast screening programmes

    Article • Annals of Oncology, August 2003, Elsevier

    Professor Peter Sasieni

  221. Outcomes of screening to prevent cancer: Think of screening as insurance

    Article • BMJ, July 2003, BMJ

    Professor Peter Sasieni

  222. The UK breast-screening programme should start at age 47 years

    Article • The Lancet, July 2003, Elsevier

    Professor Peter Sasieni

  223. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories

    Article • British Journal of Cancer, July 2003, Springer Science + Business Media

    Professor Peter Sasieni

  224. Iterated residuals and time-varying covariate effects in Cox regression

    Article • Journal of the Royal Statistical Society Series B Statistical Methodology, April 2003, Wiley

    Professor Peter Sasieni

  225. X-inactivation patch size in human female tissue confounds the assessment of tumor clonality

    Article • Proceedings of the National Academy of Sciences, February 2003, Proceedings of the National Academy of Sciences

    Professor Peter Sasieni

  226. On the Expected Number of Cancer Deaths During Follow-Up of an Initially Cancer-Free Cohort

    Article • Epidemiology, January 2003, Wolters Kluwer Health

    Professor Peter Sasieni

  227. The Influence of Genetics and Environmental Factors in the Pathogenesis of Acne: A Twin Study of Acne in Women

    Article • Journal of Investigative Dermatology, December 2002, Elsevier

    Professor Peter Sasieni

  228. Could HPV testing become the sole primary cervical screening test?

    Article • Journal of Medical Screening, June 2002, SAGE Publications

    Professor Peter Sasieni

  229. Adjusted Nelson–Aalen Estimates With Retrospective Matching

    Article • Journal of the American Statistical Association, March 2002, Taylor & Francis

    Professor Peter Sasieni

  230. How Many Mutations in a Cancer?

    Article • American Journal Of Pathology, March 2002, Elsevier

    Professor Peter Sasieni

  231. A weighted Kaplan-Meier estimator for matched data with application to the comparison of chemotherapy and bone-marrow transplant in leukaemia

    Article • Statistics in Medicine, January 2002, Wiley

    Professor Peter Sasieni

  232. Natural history of cervical human papillomavirus

    Article • The Lancet, November 2001, Elsevier

    Professor Peter Sasieni

  233. Routine audit is an ethical requirement of screening

    Article • BMJ, May 2001, BMJ

    Professor Peter Sasieni

  234. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England

    Article • The Lancet, May 2001, Elsevier

    Professor Peter Sasieni

  235. Genetics of Risk Factors for Melanoma: an Adult Twin Study of Nevi and Freckles

    Article • JNCI Journal of the National Cancer Institute, March 2000, Oxford University Press (OUP)

    Professor Peter Sasieni

  236. Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model

    Article • BMJ, May 1999, BMJ

    Professor Peter Sasieni

  237. Standardized Lifetime Risk

    Article • American Journal of Epidemiology, May 1999, Oxford University Press (OUP)

    Professor Peter Sasieni

  238. Invited review. Statistical analysis of the performance of diagnostic tests

    Article • Cytopathology, March 1999, Wiley

    Professor Peter Sasieni

  239. Melanoma yield, number of biopsies and missed melanomas in a British teaching hospital pigmented lesion clinic: a 9-year retrospective study

    Article • British Journal of Dermatology, February 1999, Wiley

    Professor Peter Sasieni

  240. Supersites within superfolds. Binding site similarity in the absence of homology 1 1Edited by J. Thornton

    Article • Journal of Molecular Biology, October 1998, Elsevier

    Professor Peter Sasieni

  241. From Genotypes to Genes: Doubling the Sample Size

    Article • Biometrics, December 1997, JSTOR

    Professor Peter Sasieni

  242. Cervical sampling devices

    Article • BMJ, November 1996, BMJ

    Professor Peter Sasieni

  243. Risk factors for invasive cervix cancer in young women

    Article • European Journal of Cancer, May 1996, Elsevier

    Professor Peter Sasieni

  244. Effect of smoking cessation on cervical lesion size

    Article • The Lancet, April 1996, Elsevier

    Professor Peter Sasieni

  245. Full description of controls is needed in study

    Article • BMJ, March 1996, BMJ

    Professor Peter Sasieni

  246. Proportional excess hazards

    Article • Biometrika, March 1996, Oxford University Press (OUP)

    Professor Peter Sasieni

  247. Dotplots

    Article • Journal of the Royal Statistical Society Series C (Applied Statistics), January 1996, JSTOR

    Professor Peter Sasieni

  248. Accelerated decline in cervical cancer mortality in England and Wales

    Article • The Lancet, December 1995, Elsevier

    Professor Peter Sasieni

  249. Non-Hodgkin's lymphoma and skin cancer

    Article • BMJ, September 1995, BMJ

    Professor Peter Sasieni

  250. Cervical screening: what is the point?

    Article • The Lancet, July 1995, Elsevier

    Professor Peter Sasieni

  251. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in denmark, 1943–1989

    Article • International Journal of Cancer, June 1995, Wiley

    Professor Peter Sasieni

  252. Risk of ocular melanoma in relation to cutaneous and IRIS naevi

    Article • International Journal of Cancer, March 1995, Wiley

    Professor Peter Sasieni

  253. Efficiently weighted estimating equations with application to proportional excess hazards

    Article • Lifetime Data Analysis, January 1995, Springer Science + Business Media

    Professor Peter Sasieni

  254. Endometriosis during tamoxifen treatment

    Article • The Lancet, April 1994, Elsevier

    Professor Peter Sasieni

  255. A partly parametric additive risk model

    Article • Biometrika, January 1994, Oxford University Press (OUP)

    Professor Peter Sasieni

  256. Some New Estimators for Cox Regression

    Article • The Annals of Statistics, December 1993, Institute of Mathematical Statistics

    Professor Peter Sasieni

  257. A Partly Parametric Additive Risk Model

    Article • January 1993, Defense Technical Information Center (DTIC)

    Professor Peter Sasieni

  258. Ingested Arsenic, Keratoses, and Bladder Cancer

    Article • American Journal of Epidemiology, August 1992, Oxford University Press (OUP)

    Professor Peter Sasieni

  259. A note on the presentation of matched case-control data

    Article • Statistics in Medicine, January 1992, Wiley

    Professor Peter Sasieni

  260. Information Bounds For the Additive and Multiplicative Intensity Models

    Article • January 1992, Springer Science + Business Media

    Professor Peter Sasieni

  261. Correspondence Effect of Introducing A Restrictive Cervical Screening Policy On the Detection of Cervical Cancer

    Article • Cytopathology, October 1991, Wiley

    Professor Peter Sasieni

  262. Trends in cervical cancer mortality

    Article • The Lancet, September 1991, Elsevier

    Professor Peter Sasieni

  263. Cervical Screening

    Article • Wiley

    Professor Peter Sasieni

  264. Survival Analysis

    Article • Springer Science + Business Media

    Professor Peter Sasieni